YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
[mrna Cancer Vaccine] wildpixel/iStock via Getty Images INVESTORS SHOULD KNOW: Personalized mRNA cancer vaccines are moving beyond their first major clinical success in melanoma into a broader test across harder-to-treat solid tumors. The…
Mentioning how the FDA advisory panel backed its Galleri multi-cancer early detection test, a caller asked for Jim Cramer's opinion on GRAIL, Inc. (NASDAQ:GRAL) during the lightning round of the September 30 episode of Mad Money. He replie…
In September 2026, GRAIL announced that its Galleri multi-cancer early detection blood test showed strong performance in the PATHFINDER 2 study and received a favorable U.S. FDA advisory committee vote supporting its safety, benefit-risk p…
[Skyline. Office skyscraper in New York City, Manhattan] ultramarinfoto Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock price…
[Ozempic Insulin injection pen] CR/iStock via Getty Images INVESTORS SHOULD KNOW: The obesity drug market is undergoing a structural shift, moving beyond the initial injectable GLP-1 franchise. Now, the industry is moving toward a broader…
* A panel of US FDA advisors voted that there is reasonable evidence that GRAIL’s (GRAL [https://seekingalpha.com/symbol/GRAL]) multi-cancer early detection blood test Galleri is effective. The vote was 6-4. * Members of the Molecular and…
MENLO PARK, Calif., Aug. 31, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Morgan Stanley 24t…
This article first appeared on GuruFocus. Total Revenue: $44.7 million, up 26% year over year. Screening Revenue: $42.6 million, up 24% year over year. Development Services Revenue: $2 million. Test Volume: Over 61,000 Galleri tests sold,…
Key Points Interested in GRAIL, Inc.? Here are five stocks we like better. Revenue and Galleri volumes grew strongly: Second-quarter revenue increased 26% year over year to $44.7 million, while Galleri test volume rose 35% to more than 61,…
Q2 Galleri® Test Volume Increased 35% to More Than 61,000 Year-Over-Year, and Galleri Revenue Grew 24% to $42.6 Million Galleri Test Volume and Revenue are up 42% and 30% Year-Over-Year, Respectively, for the First Half of the Year NHS-Gal…
SAN FRANCISCO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in GRAIL, Inc. (NASDAQ: GRAL) that a securities fraud class action lawsuit has been filed, and the firm is actively urging investors with sub…
Jazz Pharmaceuticals (JAZZ) came out with quarterly earnings of $5.71 per share, missing the Zacks Consensus Estimate of $6.04 per share. This compares to a loss of $8.25 per share a year ago. These figures are adjusted for non-recurring i…
Key Points Grail’s stock crashed after Galleri’s NHS England trial missed its primary endpoint. But it’s still generating plenty of revenue without an FDA approval.10 stocks we like better than Grail › Grail (NASDAQ: GRAL), which was spun…
Grail (NASDAQ: GRAL), which was spun off from Illumina (NASDAQ: ILMN) in 2024, reached a record high of $116.06 on Jan. 22. But today, the cancer test developer's stock trades at just under $70. Is it a buy, sell, or hold at these levels?I…
NEW YORK, Aug. 01, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GRAIL, Inc. (NASDAQ: GRAL) between May 13, 2025 and February 19, 2026, inclusive (the “Class Period”)…
ניו יורק, Aug. 01, 2026 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשי המניות הרגילות של GRAIL, Inc. (נאסד"ק: GRAL) בין התאריכים 13במאי 2025 עד 19בפברואר 2026, שנ…
BENSALEM, Pa., July 30, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the dea…
Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourages Investors Who Suffered Losses In GRAIL (GRAL) To Contact Him Directly To Discuss Their Options If you purchased or acquired Grail common stock…
ATLANTA, July 29, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Grail, Inc. (“Grail”) (NASDAQ: GRAL). The lawsuit alleges that Defendants made false and misleading statements and/or failed to disclose m…
SAN DIEGO, July 29, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of GRAIL, Inc. (NASDAQ: GRAL) common stock between May 13, 2025 and February 19, 2026, both dates inclusiv…
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds GRAIL, Inc. (“GRAIL” or the “Company”) (NASDAQ: GRAL) investors of the August 4, 2026 deadline involving a securit…
LOS ANGELES, July 28, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the dea…
紐約, July 27, 2026 (GLOBE NEWSWIRE) -- 事因：全球投資者權益律師事務所 Rosen Law Firm 提醒在 2025 年 5 月 13 日至 2026 年 2 月 19 日（包括首尾兩日，下稱「集體訴訟期」）期間購買了 GRAIL, Inc. (NASDAQ: GRAL) 普通股之人士注意，重要的首席原告截止日期為 2026 年 8 月 4 日。 影響：如果您在集體訴訟期間購買 GRAIL 普通股，您可能有權透過勝訴收費安排獲得賠償，而…
NEW YORK, July 26, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GRAIL, Inc. (NASDAQ: GRAL) between May 13, 2025 and February 19, 2026, inclusive (the “Class Period”)…
SAN FRANCISCO, July 25, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in GRAIL, Inc. (NASDAQ: GRAL) that a securities fraud class action lawsuit has been filed, and the firm is actively urging investors with sub…
SAN FRANCISCO, July 24, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in GRAIL, Inc. (NASDAQ: GRAL) that a securities fraud class action lawsuit has been filed, and the firm is actively urging investors with sub…
NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of GRAIL, Inc. (NASDAQ: GRAL). Shareholders who purchased shares of GRAL during the class period listed are encouraged to contact th…
NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against GRAIL, Inc. (NASDAQ:GRAL) and certain of the Company’s senior executives for se…
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against GRAIL, Inc. (“Grail” or the “Company”) (NASDAQ: GRAL). Such investors are advised to contact Danielle Peyton at newactio…
LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Grail, Inc., (“Grail” or the "Company") (NASDAQ: GRAL) investors of a class action on behalf of investors that bought securities between May 13, 2025 and February…
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GRAIL, Inc. (NASDAQ: GRAL) between May 13, 2025 and February 19, 2026, inclusive (the “Class Period”)…
Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourages Investors Who Suffered Losses In GRAIL (GRAL) To Contact Him Directly To Discuss Their Options If you purchased or acquired Grail common stock…
LOS ANGELES, July 20, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 4, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or ot…
SAN FRANCISCO, July 20, 2026 (GLOBE NEWSWIRE) -- National shareholder rights firm Hagens Berman is investigating claims in a pending class action alleging violations of U.S. securities laws by GRAIL, Inc. (NASDAQ: GRAL). The suit contends…
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against GRAIL, Inc. (NASDAQ:GRAL) and certain of the Company’s senior executives for se…
ATLANTA, July 18, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: Badger Meter, Inc. (BMI) The shareholder class action lawsuit…